This is the same mechanism used by the bodys own GHRH, which means sermorelin: Preserves the natural pulsatile pattern of GH release Maintains somatostatin feedback inhibition Supports long-term pituitary function rather than suppressing it Works synergistically with exercise and sleep, which naturally enhance GHRH signaling Clinical History Sermorelin has a notable clinical history
MK-677 (Ibutamoren) MK-677 (ibutamoren) is an orally active, non-peptide small molecule agonist of the ghrelin receptor (GHSR-1a) that stimulates endogenous growth hormone and IGF-1 secretion, studied in randomized trials in older adults, obesity, and sleep research
Instead of introducing a synthetic growth hormone into your body, CJC 1295 and Ipamorelin work by gently signaling your own pituitary gland to produce and release more of its own growth hormone
The biggest known risks are retatrutide-driven GI side effects (nausea 38-43%, diarrhea 33-35%) and dysesthesia - an unusual skin tingling or burning sensation at higher doses
doi: 10.1038/s41467-021-26735-5 52 LundL